121 related articles for article (PubMed ID: 38230627)
21. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
23. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
Calip GS; Elmore JG; Boudreau DM
Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
25. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
Yang R; Tang J; Kuang M; Liu H
Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446
[TBL] [Abstract][Full Text] [Related]
26. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
[TBL] [Abstract][Full Text] [Related]
27. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
28. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
Brummel A; Carlson AM
J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
[TBL] [Abstract][Full Text] [Related]
30. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors: a population-based study.
Kurdi AIB; Elliott RA; Chen LC
J Hypertens; 2019 Jun; 37(6):1285-1293. PubMed ID: 30601319
[TBL] [Abstract][Full Text] [Related]
31. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
32. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
[TBL] [Abstract][Full Text] [Related]
33. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
34. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
35. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive drug treatment changes in the general population: the CoLaus study.
Christe V; Waeber G; Vollenweider P; Marques-Vidal P
BMC Pharmacol Toxicol; 2014 Mar; 15():20. PubMed ID: 24685255
[TBL] [Abstract][Full Text] [Related]
37. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
Vila-Corcoles A; Satue-Gracia E; Ochoa-Gondar O; Torrente-Fraga C; Gomez-Bertomeu F; Vila-Rovira A; Hospital-Guardiola I; de Diego-Cabanes C; Bejarano-Romero F; Rovira-Veciana D; Basora-Gallisa J
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1379-1388. PubMed ID: 32710674
[TBL] [Abstract][Full Text] [Related]
38. Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease.
Hsu CN; Huang SH; Tain YL
BMC Pediatr; 2019 Feb; 19(1):64. PubMed ID: 30786856
[TBL] [Abstract][Full Text] [Related]
39. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
Panjabi S; Lacey M; Bancroft T; Cao F
J Am Soc Hypertens; 2013; 7(1):46-60. PubMed ID: 23321404
[TBL] [Abstract][Full Text] [Related]
40. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
